BACKGROUND: The comparative performance of existing models for prediction of type 2 diabetes across populations has not been investigated. We validated existing non-laboratory-based models and assessed variability in predictive performance in European populations. METHODS: We selected non-invasive prediction models for incident diabetes developed in populations of European ancestry and validated them using data from the EPIC-InterAct case-cohort sample (27,779 individuals from eight European countries, of whom 12,403 had incident diabetes). We assessed model discrimination and calibration for the first 10 years of follow-up. The models were first adjusted to the country-specific diabetes incidence. We did the main analyses for each country ...
OBJECTIVE: To identify existing prediction models for the risk of development of type 2 diabetes and...
Objective: To identify existing prediction models for the risk of development of type 2 diabetes and...
AIMS: To develop and validate a recalibrated prediction model (SCORE2-Diabetes) to estimate the 10-y...
SummaryBackgroundThe comparative performance of existing models for prediction of type 2 diabetes ac...
BACKGROUND: The comparative performance of existing models for prediction of type 2 diabetes across ...
SummaryBackgroundThe comparative performance of existing models for prediction of type 2 diabetes ac...
BACKGROUND: The comparative performance of existing models for prediction of type 2 diabetes across ...
Background The comparative performance of existing models for prediction of type 2 diabetes across p...
Background: The comparative performance of existing models for prediction of type 2 diabetes across ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
The comparative performance of existing models for prediction of type 2 diabetes across populations ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
OBJECTIVE: To identify existing prediction models for the risk of development of type 2 diabetes and...
Objective: To identify existing prediction models for the risk of development of type 2 diabetes and...
AIMS: To develop and validate a recalibrated prediction model (SCORE2-Diabetes) to estimate the 10-y...
SummaryBackgroundThe comparative performance of existing models for prediction of type 2 diabetes ac...
BACKGROUND: The comparative performance of existing models for prediction of type 2 diabetes across ...
SummaryBackgroundThe comparative performance of existing models for prediction of type 2 diabetes ac...
BACKGROUND: The comparative performance of existing models for prediction of type 2 diabetes across ...
Background The comparative performance of existing models for prediction of type 2 diabetes across p...
Background: The comparative performance of existing models for prediction of type 2 diabetes across ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
The comparative performance of existing models for prediction of type 2 diabetes across populations ...
Objective To identify existing prediction models for the risk of development of type 2 diabetes and ...
OBJECTIVE: To identify existing prediction models for the risk of development of type 2 diabetes and...
Objective: To identify existing prediction models for the risk of development of type 2 diabetes and...
AIMS: To develop and validate a recalibrated prediction model (SCORE2-Diabetes) to estimate the 10-y...